Timing of PSA response to guide cessation of docetaxel in prostate cancer.

被引：0
|
作者：
Dickinson, Peter D.
Malik, Jahangeer
Slevin, Finbar
Sivanandan, Ananth
Clarke, Noel W.
Choudhury, Ananya
Elliott, Tony
机构：
[1] Christie Hosp NHS Fdn Trust, Manchester, Lancs, England
[2] NHS Lothian, Western Gen Hosp, Edinburgh, Midlothian, Scotland
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16069
引用
收藏
页数：1
相关论文
共 50 条
  • [11] Understanding docetaxel and cabazitaxel modes of action in prostate cancer.
    Nelius, Thomas
    Jarvis, Courtney
    Filleur, Stephanie
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [12] Prostate cancer recurrence: can PSA guide imaging?
    P. Mapelli
    V. Panebianco
    Maria Picchio
    European Journal of Nuclear Medicine and Molecular Imaging, 2015, 42 : 1781 - 1783
  • [13] Prostate cancer recurrence: can PSA guide imaging?
    Mapelli, P.
    Panebianco, V.
    Picchio, Maria
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 (12) : 1781 - 1783
  • [14] Effect of PSA and Gleason score on survival of metastatic prostate cancer.
    Master, Samip R.
    Shi, Runhua
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [15] FREQUENCY OF PSA TESTING IN MEN ON ACTIVE SURVEILLANCE FOR PROSTATE CANCER.
    Bokhorst, Leonard
    Alberts, Arnout
    Kakehi, Yoshiyuki
    Rannikko, Antti
    Pickles, Tom
    Valdagni, Riccardo
    Bangma, Chris
    Roobol, Monique
    JOURNAL OF UROLOGY, 2015, 193 (04): : E755 - E755
  • [16] Malpractice implications of PSA testing for early detection of prostate cancer.
    Collins, MFM
    Barry, MJ
    Roberts, RG
    Fowler, FJ
    JOURNAL OF INVESTIGATIVE MEDICINE, 1996, 44 (07) : A406 - A406
  • [17] Novel PSA binding peptides as tools in the diagnosis of prostate cancer.
    Leinonen, J
    Wu, P
    Narvanen, A
    Pakkala, M
    Karonen, S
    Stenman, U
    CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3729S - 3729S
  • [18] Defining a new threshold for PSA outcomes in untreated prostate cancer.
    Beekman, KW
    Wilton, A
    Heller, G
    Bianco, FJ
    Lilja, H
    Slovin, S
    Scardino, PT
    Scher, HI
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 403S - 403S
  • [19] Outcome, costs and dollar value of docetaxel and abiraterone in prostate cancer.
    Guirgis, Helmy M.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [20] Comparison of prostate specific antigen (PSA) density of the transition zone with percent free PSA and other PSA indexes in the detection of prostate cancer.
    Kamoi, K
    Troncoso, P
    Ramirez, EI
    Babaian, RJ
    JOURNAL OF UROLOGY, 1998, 159 (05): : 235 - 235
12345